Immunogenicity 12237
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
OR9K2
Transcript ID
uc010spe.2
HLA INFO
A*24:02
TCR INFO
No TCR info found!
Full length protein sequence (335 aa)
MLGSK
1
PRVHL
6
YILPC
11
ASQQV
16
STMGD
21
RGTSN
26
HSEMT
31
DFILA
36
GFRVR
41
PELHI
46
LLFLL
51
FLFVY
56
AMILL
61
GNVGM
66
MTIIM
71
TDPRL
76
NTPMY
81
FFLGN
86
LSFID
91
LFYSS
96
VIEPK
101
AMINF
106
WSENK
111
SISFA
116
GCVAQ
121
LFLFA
126
LLIVT
131
EGFLL
136
AAMAY
141
DRFIA
146
ICNPL
151
LYSVQ
156
MSTRL
161
CTQLV
166
AGSYF
171
CGCIS
176
SVIQT
181
SMTFT
186
LSFCA
191
SRAVD
196
HFYCD
201
SRPLQ
206
RLSCS
211
DLFIH
216
RMISF
221
SLSCI
226
IILPT
231
IIVII
236
VSYMY
241
IVSTV
246
LKIHS
251
TEGHK
256
KAFST
261
CSSHL
266
GVVSV
271
LYGAV
276
FFMYL
281
TPDRF
286
PELSK
291
VASLC
296
YSLVT
301
PMLNP
306
LIYSL
311
RNKDV
316
QEALK
321
KFLEK
326
KNIIL
331
Mutation Information
DNA mutation:
None
Peptide Range:
161 ~ 185
Mut AA position:
173 (13 in Wild Type peptide)
Alignment
Wild Type:
"MSTRLCTQLVAGSYFCGCISSVIQT
||||||||||||.||||||||||||
Mutant:
MSTRLCTQLVAGFYFCGCISSVIQT"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) OR9K2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay